Skip to main content

Advertisement

Log in

Main Aspects of Pharmaceutical Gel Development for Peroral Administration

  • DRUG SYNTHESIS METHODS AND MANUFACTURING TECHNOLOGY
  • Published:
Pharmaceutical Chemistry Journal Aims and scope

The main development issues for pharmaceutical gels for peroral administration, a modern dosage form, are reviewed. Patent and literature searches for gel forms for peroral administration were performed. The main development issues for gels for peroral administration are the need for an experimental and science-based approach to correcting the taste, providing the optimal rheological characteristics that determine the stability to aggregation and release of active ingredients from the dosage form, and selecting the packaging and dispensing device for improved therapeutic efficacy. Principles for designing peroral formulations as gels with prolonged release are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.

Similar content being viewed by others

References

  1. U. S. Food & Drug Administration; https: //www.fda.gov (accessed Oct. 12, 2017).

  2. British Pharmacopoeia, Vol. III, Health & Medicine, 2017.

  3. European Pharmacopoeia, 9.0 th Ed., Vol. I, EDQM, 2017, pp. 890 – 892.

  4. Japanese Pharmacopoeia, 16th Ed., 2011, p. 11.

  5. State Drug Registry; http: //www.grls.rosminzdrav.ru/Default.aspx (accessed Oct. 20, 2017).

  6. Encyclopedia of Pharmacy Drugs and Goods [in Russian], RLS; https: // www.rlsnet.ru (accessed Sept. 13, 2017).

  7. N. Ringarp, C. Rydberg, O. Damberg, and B. Bostrom, Zentralbl. Veterinarmed. A, 14(3), 242 – 251 (1967).

    Article  CAS  Google Scholar 

  8. H. Ueda, H. Ikeda, Y. Sasaki, et al., Tohoku J. Exp. Med., 124(1), 1 – 11(1978).

    Article  CAS  Google Scholar 

  9. US National Library of Medicine; https: //www.ncbi.nlm.nih.gov/pubmed/?term=”oral+gel” (accessed Oct. 30, 2017).

  10. L. C. Dong and A. S. Hoffman, J. Controlled Release, 15(2), 141 – 152 (1991).

    Article  CAS  Google Scholar 

  11. I. C. Kwon, Y. H. Bae, and S. W. Kim, Nature, 354(6351), 291 – 293 (1991).

    Article  CAS  Google Scholar 

  12. D. Shiino, Y. Murata, K. Kataoka, et al., Biomaterials, 15(2), 121 – 128 (1994).

    Article  CAS  Google Scholar 

  13. N. Kawasaki, R. Ohkura, S. Miyazaki, et al., Int. J. Pharm., 181(2), 227 – 234 (1991).

    Article  Google Scholar 

  14. S. Miyazaki, N. Kawasaki, K. Endo, and D. Attwood, J. Pharm. Pharmacol., 53(9), 1185 – 1191 (2001).

    CAS  Google Scholar 

  15. A. Lohani, Formulation, Development and Evaluation of Ciprofloxacin Hydrochloride Soft Gel for Oral Administration; http: // www.pharmatutor.org/articles/formulation-developmentand- evaluation-of-ciprofloxacin (accessed Aug. 14, 2017).

  16. S. Miyazaki, A. Takahashi, K. Itoh, et al., Drug Dev. Ind. Pharm., 35(7), 780 – 790 (2009).

    Article  CAS  Google Scholar 

  17. S. Miyazaki, M. Ishitani, A. Takahashi, et al., Biol. Pharm. Bull., 34(1), 164 – 166 (2011).

    Article  CAS  Google Scholar 

  18. J. Iqbal and J. Moller Haus, Eur. J. Pharm. Biopharm., 80(1), 95 – 102 (2012).

    Article  CAS  Google Scholar 

  19. P. Vijayanand, J. Patil, and M. Reddy, Braz. J. Pharm. Sci., 52(1), 127 – 131 (2016).

    Article  Google Scholar 

  20. Y. Hishikawa, Y. Kakino, H. Tsukamoto, et al., Chem. Pharm. Bull., 64, 1450 – 1457 (2016).

    Article  CAS  Google Scholar 

  21. R. O. Williams III, D. R. Taft, and J. T. McConville, INFORMA Healthcare, Taylor & Francis Group, LLC, New York, 229, 2008.

  22. M. N. Anurova, E. O. Bakhrushina, and N. B. Demina, Khim.- farm. Zh., 49(9), 57 – 64 (2015); M. N. Anurova, E. O. Bakhrushina, and N. B. Demina, Pharm. Chem. J., 49(9), 627 – 634 (2015).

  23. N. B. Demina, Pharm. Chem. J., 50(7), 475 – 480 (2016).

    Article  CAS  Google Scholar 

  24. M. N. Anurova, E. O. Bakhrushina, and S. P. Krechetov, Razrab. Regist. Lek. Sredstv, 4(17), 46 – 52 (2016).

    Google Scholar 

  25. M. N. Anurova, E. O. Bakhrushina, and N. B. Demina, Razrab. Regist. Lek. Sredstv, 4(13), 64 – 74 (2015).

    Google Scholar 

  26. T. G. Yarnykh, A. I. Tikhonov, O. A. Garkavtseva, and N. V. Romanenko, Provizor, No. 21, (2009); http: // provisor.com.ua/archive/ 2009/N21/prlapt219.php (accessed Dec. 1, 2017).

  27. J. Chirag, S. Patel, S. Tyagi, and M. Dhruv, J. Drug Discovery Ther., 15, 39 – 46 (2013).

    Google Scholar 

  28. S. B. Ahire, V. H. Bankar, P. D. Gayakwad, and S. P. Pawar Pharma Sci. Monit., 3(3), 68 – 82 (2012).

    CAS  Google Scholar 

  29. A. Ya. Malkin and A. U. Isaev, Rheology: Concepts, Methods, Applications [transl. from Engl.], TsOP Professiya, St. Petersburg, 2010, p. 356.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N. B. Demina.

Additional information

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 53, No. 9, pp. 23 – 32, September, 2019.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bakhrushina, E.O., Anurova, M.N., Demina, N.B. et al. Main Aspects of Pharmaceutical Gel Development for Peroral Administration. Pharm Chem J 53, 838–844 (2019). https://doi.org/10.1007/s11094-019-02087-9

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-019-02087-9

Keywords

Navigation